DIVIDEND ANNOUNCEMENT: AbbVie Inc (NYSE:ABBV) on 02/16/2023 declared a dividend of $1.4800 per share

AbbVie Inc (NYSE:ABBV) on 02/16/2023 declared a dividend of $ 1.4800 per share payable on May 15, 2023 to shareholders of record as of April 14, 2023.

AbbVie Inc (NYSE:ABBV) has paid dividends since 2013, has a current dividend yield of 3.9189727306% and has increased its dividends for 9 successive years.

AbbVie Inc's market cap is $ 267,146,739,860 and has a PE ratio of 20.17. The stock price closed yesterday at $ 151.06 and has a 52 week low/high of $ 134.09 and $ 175.91.

AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and The Juvederm Collection of Fillers; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon and Synthroid.

For more information on AbbVie Inc click here.